CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Senseonics Holdings, Inc. - SENS CFD

0.4188
4.77%
Market Trading Hours* (UTC) Opens on Wednesday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.0140
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024346 %
Charges from full value of position ($-4.63)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002124 %
Charges from full value of position ($0.40)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.002124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 0.4398
Open 0.4429
1-Year Change -36.13%
Day's Range 0.4027 - 0.4429
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 17, 2024 0.4188 -0.0143 -3.30% 0.4331 0.4536 0.3914
Dec 16, 2024 0.4398 -0.0195 -4.25% 0.4593 0.5243 0.4342
Dec 13, 2024 0.4437 -0.0456 -9.32% 0.4893 0.5221 0.4250
Dec 12, 2024 0.4200 0.0552 15.13% 0.3648 0.4589 0.3596
Dec 11, 2024 0.3359 0.0180 5.66% 0.3179 0.3747 0.3135
Dec 10, 2024 0.3030 0.0202 7.14% 0.2828 0.3213 0.2828
Dec 9, 2024 0.2769 0.0168 6.46% 0.2601 0.2920 0.2514
Dec 6, 2024 0.2483 -0.0106 -4.09% 0.2589 0.2721 0.2483
Dec 5, 2024 0.2501 -0.0259 -9.38% 0.2760 0.2764 0.2491
Dec 4, 2024 0.2759 -0.0300 -9.81% 0.3059 0.3144 0.2736
Dec 3, 2024 0.3036 0.0056 1.88% 0.2980 0.3154 0.2980
Dec 2, 2024 0.3061 0.0022 0.72% 0.3039 0.3205 0.2999
Nov 29, 2024 0.3093 0.0014 0.45% 0.3079 0.3251 0.2987
Nov 27, 2024 0.3040 0.0037 1.23% 0.3003 0.3071 0.2984
Nov 26, 2024 0.2923 -0.0030 -1.02% 0.2953 0.3065 0.2923
Nov 25, 2024 0.3013 -0.0133 -4.23% 0.3146 0.3202 0.3003
Nov 22, 2024 0.3115 0.0042 1.37% 0.3073 0.3219 0.3073
Nov 21, 2024 0.3192 0.0113 3.67% 0.3079 0.3273 0.3064
Nov 20, 2024 0.3149 0.0188 6.35% 0.2961 0.3244 0.2942
Nov 19, 2024 0.3160 0.0181 6.08% 0.2979 0.3183 0.2922

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Senseonics Holdings, Inc. Company profile

Senseonics Holdings is a medical technology company that develops and manufactures continuous glucose monitoring (CGM) systems, specialising in long-term, implantable CGM systems for diabetes patients. It was founded in 1996 and trades on the New York Stock Exchange (NYSE) under the ticker SENS.

Headquartered in Maryland, US, the company had its initial public offering (IPO) in 2016, with an underwritten public offering of 15,800,000 shares of its common stock at $2.85 a share. Leerink Partners LLC and Canaccord Genuity acted as joint book-running managers for the offering, with Raymond James & Associates as lead manager and BTIG LLC as co-manager.

In February 2022, Senseonics’ Eversense E3 Continuous Glucose Monitoring System, touted as the first and only such CGM system, was approved for use for up to six months by the US Food and Drug Administration (FDA). The technology was reported to be available to patients in the US by the second quarter of 2022 through Senseonics’ global commercial partner, Ascensia Diabetes Care

The company’s partnership with Ascencia began in August 2020, when the pair announced a collaboration and commercialisation agreement that made Ascencia the sole distributor of Senseonics’ Eversense CGM systems worldwide. At that same time, Seseonics announced a financing agreement with Ascencia’s parent company, Masters Special Situations. The two agreements collectively made for $80m of debt and equity capital.

Industry: Medical Equipment, Supplies & Distribution (NEC)

20451 Seneca Meadows Pkwy
GERMANTOWN
MARYLAND 20876-7005
US

People also watch

BTC/USD

104,972.70 Price
-1.240% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Gold

2,644.96 Price
+0.040% 1D Chg, %
Long position overnight fee -0.0055%
Short position overnight fee -0.0027%
Overnight fee time 22:00 (UTC)
Spread 0.30

US100

22,032.80 Price
+0.280% 1D Chg, %
Long position overnight fee -0.0243%
Short position overnight fee 0.0021%
Overnight fee time 22:00 (UTC)
Spread 1.8

ETH/USD

3,866.61 Price
-1.610% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading